Chinese CoronaVac Vaccine Analysis Continues



Samples of the CoronaVac vaccine brought to the Turkish capital last week are being tested in health ministry labs for emergency use approvals, the ministry said on Tuesday.

Samples of the vaccine, developed by Chinese company Sinovac Biotech, which were brought in on December 30, 2020, are being tested in accordance with routine quality control processes applied around the world, he said in a statement.

Analyzes are underway to verify the expected quality, efficacy and reliability of the vaccine when stored and applied under company-defined conditions throughout its shelf life, the statement added.

If it passes tests for at least 14 days, the vaccine will be put into use after “emergency use approval” by the Turkish Pharmaceuticals and Medical Devices Institution, according to the ministry.

The institution’s laboratories, called national control laboratories, are recognized and accredited by equivalent international institutions and organizations.

All vaccines listed in the ministry’s vaccination program, as well as medical biologics, drugs, enteral nutrition products and medical foods, medical devices, biocidal products and cosmetics, are tested in these laboratories.

Health workers and nursing homes will be the first to receive the vaccines, according to Health Minister Fahrettin Koca.

The vaccine will be applied by the COVID-19 vaccine application units of the Ministry of Health which will be established in family health centers, private and university hospitals, according to the Directorate of Health Services.

Those who wish to be vaccinated will contact these units by appointment.

Turkey confirmed 13,695 new cases on Monday, including 1,508 symptomatic patients, bringing the number of infections to more than 2.25 million.

The COVID-19 death toll in the country currently stands at 21,685.

* Written by Havva Kara Aydin

Health Ministry laboratories continue to analyze COVID-19 vaccines

The Anadolu Agency website contains only a portion of the stories offered to subscribers in the AA News Distribution System (HAS), and in summary form. Please contact us for subscription options.


Leave A Reply